Blog

3 Amazing Keynotes Announced For PPMD’s 2022 Conference — Including YouTube Stars Shane & Hannah Burcaw!

Keynote Lineup Announced For PPMD’s 2022 Annual Conference! We are thrilled to announce our Keynote speaker lineup for PPMD’s 2022 Annual Conference, being held June 23-26 in Scottsdale, AZ (and virtually!). Alongside our already robust Conference…

Learn More

BIG NEWS! $500 Travel Reimbursement for PPMD’s Annual Conference Available Through Memorial Day!

Thanks to generous donations and sponsorships, PPMD is thrilled to announce that we are able to provide a $500 travel reimbursement opportunity to all Duchenne/Becker families attending PPMD’s 2022 Annual Conference, June 23-26 in Scottsdale,…

Learn More

2022 End Duchenne Tour Recap: Atlanta, GA

2022 End Duchenne Tour Recap: Atlanta, GA The PPMD team was excited to travel to Atlanta for our first in-person End Duchenne Tour stop since 2020. More than 30 people came together to hear about…

Learn More

Win a NEW Xbox Series X with PPMD’s Duchenne Registry!

Win a NEW Xbox Series X! For all of you gamers and parents of gamers, PPMD’s Duchenne Registry is excited to announce we will be giving away a brand new Xbox Series X to one…

Learn More

Nationwide Children’s Announces Restoration of Full-Length Dystrophin Using Dup 2 Gene Therapy Approach

PPMD is very excited to see promising results shared from Nationwide Children’s scAAV9.U7.ACCA gene therapy trial, a Phase 1/2 study aiming to induce exon skipping for individuals with a duplication of exon 2 to restore full-length…

Learn More

WATCH: PPMD & Pfizer Discuss Updates on CIFFERO Phase 3 Gene Therapy Trial

Recently Pat Furlong, PPMD’s founder and CEO, sat down with Dr. Beth Belluscio, Pfizer’s Global Clinical Lead of Rare Neurological Disorders, to discuss Pfizer’s learnings from previous gene therapy studies and updates on the CIFFERO…

Learn More

Entrada Therapeutics Shares New Data on ENTR-601-44 Exon Skipping Therapy

Entrada Therapeutics has shared new data from a preclinical study evaluating ENTR-601-44, an exon-skipping therapy set to target individuals with Duchenne amenable to exon 44 skipping. We are pleased to hear new data on this…

Learn More

Sign up today! Virtual Race Series-Power of Us

Sign up today for the Race to End Duchenne Virtual Race Series-May 21, 2022 – June 19, 2022! The Power of Us is stronger than any one of us alone. Join us for the Race…

Learn More

PPMD Announces 30th Certified Duchenne Care Center at Helen DeVos Children’s Hospital

Today Parent Project Muscular Dystrophy announced the expansion of our renowned Certified Duchenne Care Center (CDCC) Program with pediatric CDCC certification of the clinic at Spectrum Health Helen DeVos Children’s Hospital (HDVCH) in Grand Rapids,…

Learn More

Race Athlete Spotlight: Catalina Rodriguez

Catalina Rodriguez joined the Race to End Duchenne team and ran the runDisney Princess 5K in February of 2022. With the support of her son and daughter, she finished with pride. Meet Catalina Why did…

Learn More

Join Our Mailing List